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Human phagocyte-speciﬁc chitotriosidase is part of innate immunity and shows anti-fungal activity
towards chitin-containing fungi. We investigated the effect of stimulation of the C-type lectin recep-
tor dectin-1 by b-1,3-glucan (curdlan) on chitotriosidase expression and release by human phago-
cytes. We observed that curdlan triggers chitotriosidase release from human neutrophils. In
addition, we show that curdlan impairs chitotriosidase induction in monocytes. Finally, curdlan
temporarily induces chitotriosidase in enzyme-expressing monocyte-derived macrophages, fol-
lowed by reduction of chitotriosidase expression after prolonged stimulation. These data on regula-
tion of phagocyte-speciﬁc chitotriosidase following curdlan recognition support an important role
of chitotriosidase in the elimination of chitin-containing pathogens.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction In addition, chitin can be recognized by the FIBCD1 gene product,Human phagocyte-speciﬁc chitotriosidase contributes to innate
immune responses towards chitin-containing fungi, both in vitro
and in vivo [1–3]. This enzyme has ﬁrst been described in Gaucher
disease patients and serves as a critical biomarker to monitor dis-
ease onset, development and therapeutic efﬁcacy [4,5]. It has been
puriﬁed from a Gaucher patient spleen and cloned from a human
macrophage (m/) cDNA library [6,7]. A close relative is acidic
mammalian chitinase (AMCase), which has been linked to asthma
[8,9].
Chitinases belong to family 18 of glycosyl hydrolases and
hydrolyze chitin, the linear polymer of N-acetylglucosamine, the
second most abundant polysaccharide in nature. Chitin serves as
an indispensable structural component in a variety of organisms,
including fungi and arthropods [5,10–13]. Chitin induces the
accumulation of IL4-expressing innate immune cells in mice and
alternative activation of m/s, with concomitant production of
leukotriene B4, which is essential for proper immune cell
recruitment [14].
In mice, chitin particles of a certain size are recognized by m/s
through toll-like receptor (TLR)-2, the C-type lectin receptor
dectin-1 and to a lesser extent by the mannose receptor [15,16].chemical Societies. Published by E
ndritic cell-associated C-type
ijk).which is expressed apically by enterocytes [17]. A secreted C-type
lectin, RegIIIc (HIP/PAP in man), is present in Paneth cell secretory
granules in the mouse and recognizes chitin as well [18].
We have previously shown that peptidoglycan triggers release
of chitotriosidase from neutrophils and that activation of nucleo-
tide-binding oligomerization domain (NOD)-2 in human m/s tem-
porarily induced this chitinase [19].
In addition to chitin, also b-glucan is a major structural compo-
nent of the fungal cell wall. Dendritic cell-associated C-type lectin-
1 (dectin-1) is involved in the innate immune recognition of this
carbohydrate [20]. Thus far it is not known if stimulation of dec-
tin-1 using b-1,3-glucan (curdlan) regulates chitotriosidase secre-
tion by human neutrophils, or inﬂuences regulation of expression
by macrophages. We therefore studied the effect of dectin-1-de-
rived signals on human phagocytic chitotriosidase expression and
release. First, enzyme release from neutrophils stimulated with
curdlan was studied. Second, it was addressed how curdlan affects
induction of chitotriosidase expression by monocytes. Finally, the
effect of curdlan on m/s, which already express the enzyme, was
determined.
2. Materials and methods
2.1. Isolation of human phagocytes and culture conditions
Monocytes and neutrophils were isolated and cultured as de-
scribed [2,19]. Monocytes were cultured in RPMI/10%HS for 7 dayslsevier B.V. All rights reserved.
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(Sigma). Chitotriosidase activity (nmol/ml*h) was determined in
cell-free culture supernatants, using ﬂuorescent 4-MU-triacylchi-
totrioside (Sigma) [2]. Alternatively, monocytes were matured for
7 days in culture medium alone towards chitotriosidase expressing
m/s, which were washed and further cultured in medium or stim-
ulated with curdlan. Next, chitotriosidase activity was determined
in cell-free supernatants at indicated time points and gene expres-
sion in response to dectin-1 triggering was analysed (see Section
2.2 below).
Neutrophils were seeded at 4 million cells in a ﬁnal volume of
200 ll RPMI/0.5% BSA and stimulated with curdlan for 90 min.
Activities of chitotriosidase were measured in cell-free neutrophil
supernatants. LY294002 was used to inhibit PI3kinase, SB302580
to inhibit p38 MAP kinase and PD98059 to inhibit p42/44 MAP ki-
nase or ERK 1/2 (all from Sigma, used at 50 lM).
2.2. Quantitative PCR
Total RNA was extracted using the nucleospin II extraction kit
(Macherey-Nagel, Düren, Germany) and concentrations were mea-
sured with the NanoDrop spectrophotometer (NanoDrop Technol-
ogies, Wilmington, DE). 500 ng of RNA per sample was transcribed
into ﬁrst strand cDNA using Superscript II reverse transcriptase
(Invitrogen). cDNA was diluted 20 times prior to gene-speciﬁc
analysis by real-time PCR applying the iCycler MyiQTM system
(Biorad Laboratories, Veenendaal, The Netherlands). Target genes
were normalized to ribosomal phosphoprotein 36B4. The following
gene-speciﬁc primers were used: CCR7 forward primer 50-tgaggt-
cacggacgattacat-30; reverse primer 50-gtaggcccacgaaacaaatgat-30;
TNFa forward primer 50-ggcgtggagctgagagata-30; reverse primer
50-cagccttggcccttgaaga-30; MIP1b/CCL4 forward primer 50-gcgtg-Fig. 1. IL8 and chitotriosidase release from human neutrophils stimulated with
curdlan. (A) IL8 release after 24 h of stimulation. (B) Chitotriosidase activity
released after 90 min of stimulation. (C) Western blot analysis of neutrophil
supernatants, following 90 min stimulation with medium or curdlan. On the y-axis
mean values ±S.D. are depicted; n = 4, **P < 0.01; ***P < 0.001.actgtcctgtctctcc-30; reverse primer 50-ccacaaagttgcgaggaagc-30;
IL10 forward primer 50-tgccttcagcagagtgaagactt-30; reverse primer
50-tcctccagcaaggactccttta-30; CCL18 forward primer 50-cccagctcac-
tctgaccact-30; reverse primer 50-gtggaatctgcc aggaggta-30; CD163
forward primer 50-gcacatcactcagaatttcaatgg-30; reverse primer 50-
acatagatcatgcatctgtcatttg-30; 36B4 forward primer 50-tcgacaatgg-
cagcatctac-30; reverse primer 50-atccgtctccacagacaagg-30. Data
were analysed using the delta Ct method [21]. Statistical analysis
was performed using the Student’s t test (GraphPad Software,
San Diego, CA). A probability value of P < 0.05 was considered to
be signiﬁcant.
2.3. Western blot analysis
Aliquots of cell-free culture supernatants were analysed for chi-
totriosidase protein. Following SDS–PAGE, proteins were trans-
ferred to nitro-cellulose (Fischer Scientiﬁc, Pittsburgh, USA) and
chitotriosidase expression was assessed using a rabbit anti-chitot-
riosidase polyclonal as described previously [19] and for detection
secondary IRDYE conjugates were used (Westburg).
3. Results
3.1. Curdlan triggers chitotriosidase release by human neutrophils
In the circulation neutrophils are the chitotriosidase-containing
cells that can contribute to ﬁrst line defence against chitin-contain-
ing pathogens. It has been demonstrated that human neutrophilsFig. 2. Signalling pathways involved in curdlan-induced release of chitotriosidase
from human neutrophils. (A) Inhibition of PI3 kinase and p38 MAP kinase reduces
release of chitotriosidase. On the y-axis mean chitotriosidase activity compared to
medium ±S.D. is depicted; n = 4, *P < 0.05; **P < 0.01. (B) Western blot analysis of
chitotriosidase protein released in neutrophil supernatants.
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in vivo [2,19]. In this way chitotriosidase contributes to chitonolyt-
ic innate anti-fungal responses. We studied whether dectin-1 stim-
ulation, using curdlan, triggered chitotriosidase release. First,
functionality of curdlan was tested. Neutrophils were stimulated
for 24 h with curdlan and we found a dose-dependent increase of
IL8 release (Fig. 1A). Next, we measured chitotriosidase activity
in cell-free culture supernatants after 90 min of stimulation with
curdlan. A signiﬁcant increase in enzyme activity was observed,
which was paralleled by increased amounts of secreted protein
as detected by western blot (Fig. 1B and C). We have excluded
the possibility that cell death caused this induction of chitotriosi-
dase release from neutrophils. Next we addressed the signalling
cascades involved in this curdlan-mediated release. Curdlan did
not trigger an increase of the intracellular Ca2+ concentration (data
not shown). Previously we have demonstrated that chitotriosidase
release induced with peptidoglycan was inhibited by the p38 MAP
kinase inhibitor SB203580 and the PI3 kinase inhibitor LY294002
[19]. Here we observed that chitotriosidase release induced by
curdlan, used at 100 lg/ml, was also reduced by about 50% by each
of these inhibitors, while their combined use completely reduced
release (Fig. 2A), suggesting that both kinases are involved in curd-Fig. 3. Stimulation of human monocytes with curdlan inhibits induction of chitotri
Chitotriosidase activity. (C) Cell viability. On the y-axis chitotriosidase activities are dep
Respective images of m/ stimulated for 7 days with medium, or curdlan (1, 10, or 100lan-induced chitinase release. Inhibition of ERK 1/2, using
PD98059, gave no signiﬁcant inhibition, suggesting that this kinase
is not essential for the curdlan-mediated release of chitotriosidase.
By western blot we conﬁrmed release of chitotriosidase at the level
of protein (Fig. 2B).
3.2. Curdlan impairs induction of chitotriosidase in human monocytes
Human chitotriosidase was discovered as the m/-speciﬁc chiti-
nase [4–7]. We ﬁrst studied the effect of curdlan on chitotriosidase
induction by human monocytes. Fresh monocytes do not express
the enzyme and require maturation towards m/s for induction.
Monocytes were matured in the presence of different concentra-
tions of curdlan. We observed a potent inhibitory effect on the
induction of chitotrioisidase expression. When compared to med-
ium-exposed monocytes, chitotriosidase expression was virtually
absent both at the level of RNA and activity (Fig. 3A and B). In part,
this reduced expression could be explained by the fact that cell via-
bility of stimulated monocytes was impaired after 7 days at the
highest concentrations used (Fig. 3C). However, at a concentration
of 1 lg/ml, curdlan did not affect viability, but still chitotriosidase
was reduced to a large extend. By microscopy we observed that theosidase synthesis. (A) Real time PCR analysis of chitotriosidase expression. (B)
icted compared to culture in medium alone ±S.D. n = 5, *P < 0.05; ***P < 0.001. (D)
lg/ml).
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The round shape of the control m/s became more protruded as
is depicted in Fig. 3D.
3.3. Curdlan temporarily induces chitotriosidase in human chitinase-
expressing m/s
We demonstrated that the induction of chitotriosidase is inhib-
ited when monocytes are stimulated with curdlan, already at the
concentration when viability is not affected. Next, it was addressed
whether curdlan affected chitotriosidase expression in m/s. To an-
swer this question matured m/s, cultured for 7 days to allow chi-
totriosidase induction, were washed and stimulated for 4 or 48 h
with curdlan. First functionality of the stimulation was deter-Fig. 4. M/ phenotype- and chitotriosidase expression in response to curdlan. (A) Real-tim
stimulation (n = 3). (B) Real time PCR analysis of anti-inﬂammatory gene expression of I
chitotriosidase activity after 4 and 48 h of stimulation. On y-axis activity is depicted
***P < 0.001.mined. By quantitative real-time PCR analysis we observed a rapid
induction of inﬂammatory genes such as TNFa, CCR7 and MIP-1b
(Fig. 4A). Anti-inﬂammatory IL10 was also highly induced after
4 h, followed by induction of the IL10-responsive genes CCL18
and CD163 after 48 h (Fig. 4B). Next we analysed chitotriosidase
activity in cell-free culture supernatants and found a minor, but
signiﬁcant, induction in the presence of curdlan after 4 h of stimu-
lation (Fig. 4C, left panel). Prolonged stimulation (48 h) showed a
reduction when compared to stimulation with medium only
(Fig. 4C, right panel). At the level of RNA, comparable effects on
expression were noted (data not shown). Furthermore, we did
not observe cell death of macrophages after 48 h of stimulation
with curdlan, which might have contributed to the reduction in
activity. Total loss of enzyme activity was not observed after 48 h.e PCR analysis of inﬂammatory gene expression of TNF, CCR7 and MIP1b after 4 h of
L10 after 4 h of stimulation and CCL18 and CD163 after 48 h (n = 3). (C) Analysis of
compared to culture in medium alone as mean ±S.D. n = 5, *P < 0.05; **P<0.01;
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Chitotriosidase has recently been implicated in anti-fungal re-
sponses and as such can be viewed as component of innate immu-
nity [1–3]. Enhanced chitotriosidase activity is for instance
observed in sera following bacterial, fungal, viral and protozoan
parasite infections [4,22–24]. Moreover, a higher risk for Gram
negative bacterial infection is observed in children treated for
AML, which have a defective chitotriosidase allele [25].
Our investigations on stimulation of human phagocytes with
the dectin-1 agonist curdlan can be summarized as follows. First,
human neutrophils release chitotriosidase from their speciﬁc gran-
ules after stimulation with curdlan. Second, induction of chitotrios-
idase is strongly reduced following stimulation of monocytes with
curdlan. Third, curdlan induces a pro-inﬂammatory response in
monocyte-derived macrophages, which is characterized by the
acute induction of TNFa, CCR7 and MIP1b. In parallel, an anti-
inﬂammatory program is activated characterized by the rapid
induction of IL10, followed by the induction of the IL10-dependent
genes CCL18 and CD163. Fourth, chitotriosidase expressing human
monocyte-derived macrophages show a short term minor induc-
tion of the chitinase, followed by a reduction after prolonged stim-
ulation. The ﬁndings reported here regarding the effects of curdlan
on chitotriosidase in human phagocytes are to our knowledge no-
vel and add to previous studies allowing for more efﬁcient chitin-
olytic responses.
In the circulation, neutrophils are abundantly present. They can
be recruited to wounds, a potential pathogen entry site, and to
other sites with infections. At these sites immediate chitinolytic
anti-pathogenic responses can be mounted as for instance GM-
CSF, TLR ligands and curdlan induce rapid release of chitotriosidase
form speciﬁc granules of neutrophils [2,19]. Thus far we have not
been able to detect AMCase activity in chitotriosidase-deﬁcient
Gaucher patient sera, nor did we detect AMCase expression in con-
trol, or Gaucher spleen (unpublished observations). Furthermore,
human monocyte-derived macrophages expressing high levels of
chitotriosidase do not express AMCase and in the presence of the
Th2 cytokine IL4 chitinase activity is virtually absent [2,8]. Lastly,
AMCase activity was undetectable in human neutrophils and mac-
rophages from chitotriosidase-deﬁcient individuals. This suggests
that in man chitotriosidase is the sole chitinase involved in phago-
cyte-mediated innate immunity. Recombinant human chitotriosi-
dase has been shown to target several fungi in vitro and in vivo,
encompassing Aspergillus niger, Aspergillus fumigatus, Candida albi-
cans and Cryptococcus neoformans [1–3]. Such fungi are for instance
recognized by TLRs and dectin-1, which have been shown to trig-
ger chitotriosidase release, thus allowing for chitin degradation
in the fungal cell wall [20,26].
The contribution of monocytes to acute chitotriosidase-medi-
ated anti-pathogenic responses can be neglected. Induction of the
chitinase takes fairly long and stimulation with curdlan, TLR li-
gands and the intracellular nucleotide-binding oligomerization do-
main ligand muramyl dipeptide, severely hampers induction of the
enzyme [19].
Stimulation of chitotriosidase expressing m/s with curdlan re-
vealed a rapid minor induction of activity, followed by a 40% reduc-
tion after 48 h of stimulation. Possibly the curdlan-mediated
induction of IL10 causes this reduction of chitotriosidase, as it
has been shown earlier that IL10 negatively regulates its expres-
sion [27]. Importantly, chitotriosidase activity is far from eradi-
cated, still granting efﬁcient chitinase responses. Combining the
latter with the neutrophil-mediated chitotriosidase responses, this
grants a very efﬁcient chitinolytic activity against chitin-contain-
ing pathogens, including fungi.References
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